Health
Promising Study Shows Ribociclib Reduces Breast Cancer Recurrence Risk in Early-Stage Patients
Novartis’ Ribociclib (Kisqali) Demonstrates Significant Reduction in Breast Cancer Recurrence A recent study presented at the American Society of Clinical…